Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Endeavor: Phase III completed enrollment

MDT completed enrollment of 436 patients in the U.S. Phase III ENDEAVOR

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE